AMO Pharma
New medicines. Better lives.
- Website
- amo-pharma.com
- Total Funding
- $60.0M
- Last Round
- $35.0M Venture RoundJan 2020
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
AMO Pharma is a privately held emerging biopharmaceutical company developing new treatments for serious and debilitating diseases including rare genetic disorders. Our goal is to identify and advance a robust pipeline of promising therapies for patient populations with significant areas of unmet need. The AMO Pharma portfolio currently includes clinical stage investigational drugs to treat neuromuscular or CNS symptoms of rare diseases.
Summary
AMO Pharma is a Biotech company. It has raised $60.0M in total across 2 rounds, most recently a $35.0M Venture Round in Jan 2020.
Funding History
Jan 2020
Sign up to see all 2 events
Funding: Private Equity through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amo-pharma"><img src="https://indexed.vc/api/badge/company/amo-pharma" alt="AMO Pharma on Indexed.vc" width="260" height="76" /></a>